纳斯达克上市资格委员会已正式批准Vivakor Inc. (VIVK) 的持续上市计划。根据该决议,只要Vivakor能在2026年4月30日之前满足所有合规要求,其普通股将继续在纳斯达克资本市场挂牌交易。
这一决定为这家专注于环境技术与医疗保健服务的公司提供了明确的路线图,以维持其上市地位。公司管理层表示将全力推进必要措施,确保在宽限期内达成监管标准。
纳斯达克上市资格委员会已正式批准Vivakor Inc. (VIVK) 的持续上市计划。根据该决议,只要Vivakor能在2026年4月30日之前满足所有合规要求,其普通股将继续在纳斯达克资本市场挂牌交易。
这一决定为这家专注于环境技术与医疗保健服务的公司提供了明确的路线图,以维持其上市地位。公司管理层表示将全力推进必要措施,确保在宽限期内达成监管标准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.